ERBB2 and colonic neoplasm: This is true for colon cancer cells where a cell-specific protein networks modulate Wnt signaling (Song et al., 2014), and for breast cancer where alterations of β-catenin levels drive the progression of the basal category of ErbB2-positive breast cancer (Tung et al., 2017).